Addition Therapeutics Presents Preclinical Proof-of-Concept Data at American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting

Addition Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting

PinkDx Publishes Groundbreaking Evidence in Endometrial Cancer Detection Using a Simple Vaginal Swab

PinkDx Scientific Breakthrough Featured on Good Morning America

Addition Therapeutics Announces $100 Million in Funding and Significant Progress Advancing Mission to Fulfill Promise of Genomic Medicine for Chronic and Rare Diseases

Montara Therapeutics Announces Development Candidate for First BrainOnly™-Enabled Program in TSC-Related Epilepsy and Appoints Chief Business Officer

Montara Therapeutics to Develop Novel Treatments Using the BrainOnly™ Platform with Grant from The Michael J. Fox Foundation

Montara Therapeutics Closes $20M Oversubscribed Seed Expansion, Appoints Troy Wilson as Chairman of the Board

PinkDx Announces Second Close of Upsized Series A Financing with New Investors Blue Venture Fund, Sandbox Clinical Ventures and BEVC

Radar Therapeutics Raises $13.4M in Seed Funding to Develop Smart Programmable Medicines Using Molecular RNA Sensors

Nosis Bio, Radar Tx, ResVita Bio Win Golden Tickets to Bakar Labs, in Collaboration With AbbVie

Insamo Launches with $12M Funding from Playground Global, venBio, and MRL Ventures Fund to Develop Best-in-Class Membrane-Permeable Macrocyclic Peptides